Supplemental Material and Methods from an Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines

Julie Dutil,Zhihua Chen,Alvaro N.A. Monteiro,Jamie K. Teer,Steven Eschrich

DOI: https://doi.org/10.1158/0008-5472.22424004.v1

2023-01-01

Abstract:Supplemental Methods descriptions and supplemental references supporting this additional text.

What problem does this paper attempt to address?

An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines

Julie Dutil,Zhihua Chen,Alvaro N. Monteiro,Jamie K. Teer,Steven A. Eschrich

DOI: https://doi.org/10.1158/0008-5472.CAN-18-2747

IF: 11.2

2019-01-01

Cancer Research

Abstract:Recent work points to a lack of diversity in genomics studies from genome-wide association studies to somatic (tumor) genome analyses. Yet, population-specific genetic variation has been shown to contribute to health disparities in cancer risk and outcomes. Immortalized cancer cell lines are widely used in cancer research, from mechanistic studies to drug screening. Larger collections of cancer cell lines better represent the genomic heterogeneity found in primary tumors. Yet, the genetic ancestral origin of cancer cell lines is rarely acknowledged and often unknown. Using genome-wide genotyping data from 1,393 cancer cell lines from the Catalogue of Somatic Mutations in Cancer (COSMIC) and Cancer Cell Line Encyclopedia (CCLE), we estimated the genetic ancestral origin for each cell line. Our data indicate that cancer cell line collections are not representative of the diverse ancestry and admixture characterizing human populations. We discuss the implications of genetic ancestry and diversity of cellular models for cancer research and present an interactive tool, Estimated Cell Line Ancestry (ECLA), where ancestry can be visualized with reference populations of the 1000 Genomes Project. Cancer researchers can use this resource to identify cell line models for their studies by taking ancestral origins into consideration.
Supplementary Figures and Tables from Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Arvind S. Mer,Wail Ba-Alawi,Petr Smirnov,Yi X. Wang,Ben Brew,Janosch Ortmann,Ming-Sound Tsao,David W. Cescon,Anna Goldenberg,Benjamin Haibe-Kains

DOI: https://doi.org/10.1158/0008-5472.22421108

2023-01-01

Abstract:Supplementary figures and tables
Supplementary Data File 3 from Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Arvind S. Mer,Wail Ba-Alawi,Petr Smirnov,Yi X. Wang,Ben Brew,Janosch Ortmann,Ming-Sound Tsao,David W. Cescon,Anna Goldenberg,Benjamin Haibe-Kains

DOI: https://doi.org/10.1158/0008-5472.22421120.v1

2023-01-01

Abstract:Pathway stability in PDXs across passages for Hallmark pathway set.
Supplementary Data File 5 from Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Arvind S. Mer,Wail Ba-Alawi,Petr Smirnov,Yi X. Wang,Ben Brew,Janosch Ortmann,Ming-Sound Tsao,David W. Cescon,Anna Goldenberg,Benjamin Haibe-Kains

DOI: https://doi.org/10.1158/0008-5472.22421114.v1

2023-01-01

Abstract:Analysis of drug response predicting biomarkers in PDXE dataset. For each tissue type and drug, association between genomic features (mutation copy number variation and gene expression) and drug response in PDXs are reported.
Supplementary Materials 2 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Humam Kadara,Li Shen,Junya Fujimoto,Pierre Saintigny,Chi-Wan Chow,Wenhua Liu,Zuoming Chu,Melinda Garcia,Mohamed Kabbout,You-Hong Fan,Carmen Behrens,Diane A. Liu,Mao Li,J. Jack Lee,Kathryn A. Gold,Jing Wang,Kevin R. Coombes,Edward S. Kim,Waun Ki Hong,Ignacio I. Wistuba

DOI: https://doi.org/10.1158/1940-6207.22524618.v1

2023-01-01

Abstract:PDF file - 6272K, Sweave report depicting complete codes used for microarray analysis and identification of genes differentially expressed by site and time
Supplementary Data File 4 from Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Arvind S. Mer,Wail Ba-Alawi,Petr Smirnov,Yi X. Wang,Ben Brew,Janosch Ortmann,Ming-Sound Tsao,David W. Cescon,Anna Goldenberg,Benjamin Haibe-Kains

DOI: https://doi.org/10.1158/0008-5472.22421117.v1

2023-01-01

Abstract:Pathway stability in PDXs across passages for Reactome pathway sets.
Supplementary Methods and Materials from A Genome-Wide Association Study of Cutaneous Squamous Cell Carcinoma among European Descendants

Satu J. Siiskonen,Mingfeng Zhang,Wen-Qing Li,Liming Liang,Peter Kraft,Tamar Nijsten,Jiali Han,Abrar A. Qureshi

DOI: https://doi.org/10.1158/1055-9965.22437534.v1

2023-01-01

Abstract:Supplementary Methods and Materials
Supplementary Data from Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Jintao Guo,Ying Zhou,Chaoqun Xu,Qinwei Chen,Zsófia Sztupinszki,Judit Börcsök,Canqiang Xu,Feng Ye,Weiwei Tang,Jiapeng Kang,Lu Yang,Jiaxin Zhong,Taoling Zhong,Tianhui Hu,Rongshan Yu,Zoltan Szallasi,Xianming Deng,Qiyuan Li

DOI: https://doi.org/10.1158/0008-5472.22361539.v1

2023-01-01

Abstract:<p>Supplementary Methods, Figures S1-S8, Table S1-S4</p>
Supplementary Figure 1 from Cancer Cell Lines As Genetic Models of Their Parent Histology: Analyses Based on Array Comparative Genomic Hybridization

Joel Greshock,Katherine Nathanson,Anne-Marie Martin,Lin Zhang,George Coukos,Barbara L. Weber,Tal Z. Zaks

DOI: https://doi.org/10.1158/0008-5472.22371074

2023-01-01

Abstract:Supplementary Figure 1 from Cancer Cell Lines as Genetic Models of Their Parent Histology: Analyses Based on Array Comparative Genomic Hybridization
Supplementary Materials and Methods from Integrative Comparison of mRNA Expression Patterns in Breast Cancers from Caucasian and Asian Americans with Implications for Precision Medicine

Yanxia Shi,Albert Steppi,Ye Cao,Jianan Wang,Max M. He,Liren Li,Jinfeng Zhang

DOI: https://doi.org/10.1158/0008-5472.22414515.v1

2023-01-01

Abstract:<p>Additional detail on the Materials and Methods used. Contains information on how we controlled False Discovery Rates, a brief description of Gene Set Enrichment Analysis, and justification for our use of Gene Expression Network Analysis.</p>
Supplementary Figure S10 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Wenju Chang,Zhou Zhang,Baoqing Jia,Kefeng Ding,Zhizhong Pan,Guoqiang Su,Wei Zhang,Tianyu Liu,Yunshi Zhong,Guodong He,Li Ren,Ye Wei,Dongdong Li,Xiaolong Cui,Jun Yang,Yixiang Shi,Marc Bissonnette,Chuan He,Wei Zhang,Jia Fan,Jianmin Xu

DOI: https://doi.org/10.1158/1078-0432.26423000

2024-01-01

Abstract:The interaction and/or co-modification modules identified from the candidate marker genes.
Supplementary Text from Integrative Genomic Characterization of Oral Squamous Cell Carcinoma Identifies Frequent Somatic Drivers

Curtis R. Pickering,Jiexin Zhang,Suk Young Yoo,Linnea Bengtsson,Shhyam Moorthy,David M. Neskey,Mei Zhao,Marcus V. Ortega Alves,Kyle Chang,Jennifer Drummond,Elsa Cortez,Tong-xin Xie,Di Zhang,Woonbok Chung,Jean-Pierre J. Issa,Patrick A. Zweidler-McKay,Xifeng Wu,Adel K. El-Naggar,John N. Weinstein,Jing Wang,Donna M. Muzny,Richard A. Gibbs,David A. Wheeler,Jeffrey N. Myers,Mitchell J. Frederick

DOI: https://doi.org/10.1158/2159-8290.22530164.v1

2023-01-01

Abstract:Supplementary Text - PDF file 435K, This file contains supplementary methods, figure legends for supplementary figures S1-S5, descriptions for supplementary tables S1-S14, legends for supplementary methods figures SM1-SM15, supplementary references 1-7, and supplementary methods figures SM1-SM15
Supplementary Data URL from an Integrated View of Copy Number and Allelic Alterations in the Cancer Genome Using Single Nucleotide Polymorphism Arrays

Xiaojun Zhao,Cheng Li,J. Guillermo Paez,Koei Chin,Pasi A. Jänne,Tzu-Hsiu Chen,Luc Girard,John Minna,David Christiani,Chris Leo,Joe W. Gray,William R. Sellers,Matthew Meyerson

DOI: https://doi.org/10.1158/0008-5472.22363572

2023-01-01

Abstract:http://research.dfci.harvard.edu/meyersonlab/snp/snp.htm
Supplementary Table S4 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Wenju Chang,Zhou Zhang,Baoqing Jia,Kefeng Ding,Zhizhong Pan,Guoqiang Su,Wei Zhang,Tianyu Liu,Yunshi Zhong,Guodong He,Li Ren,Ye Wei,Dongdong Li,Xiaolong Cui,Jun Yang,Yixiang Shi,Marc Bissonnette,Chuan He,Wei Zhang,Jia Fan,Jianmin Xu

DOI: https://doi.org/10.1158/1078-0432.26422958.v1

2024-01-01

Abstract:Differetially modified gene bodies between CRC/AA and controls.
Supplementary Methods from Distinguishing Cancer-Associated Missense Mutations from Common Polymorphisms

Joshua S. Kaminker,Yan Zhang,Allison Waugh,Peter M. Haverty,Brock Peters,Dragan Sebisanovic,Jeremy Stinson,William F. Forrest,J. Fernando Bazan,Somasekar Seshagiri,Zemin Zhang

DOI: https://doi.org/10.1158/0008-5472.22367003

2023-01-01

Abstract:Supplementary Methods from Distinguishing Cancer-Associated Missense Mutations from Common Polymorphisms
Supplementary Tables 1, 2, 4, 6, 9 - 12 from Proteogenomic Analysis Reveals Unanticipated Adaptations of Colorectal Tumor Cells to Deficiencies in DNA Mismatch Repair

Patrick J. Halvey,Xiaojing Wang,Jing Wang,Ajaz A. Bhat,Punita Dhawan,Ming Li,Bing Zhang,Daniel C. Liebler,Robbert J.C. Slebos

DOI: https://doi.org/10.1158/0008-5472.22402437.v1

2023-01-01

Abstract:PDF file - 121K, Table S1. Genetic features of cell lines. Table S2. Summary of standard search results. Table S4. Summary of customized search results. Table S6. SelTarBase gene list. Table S9. Parameters for MRM analyses. Table S10. Detailed co-expression module results. Table S11. Observed variant peptides Table S12. Mapping of co-expression cluster results.
Supplementary Methods from an Integrated Genome-Wide Approach to Discover Tumor-Specific Antigens As Potential Immunologic and Clinical Targets in Cancer

Qing-Wen Xu,Wei Zhao,Yue Wang,Maureen A. Sartor,Dong-Mei Han,Jixin Deng,Rakesh Ponnala,Jiang-Ying Yang,Qing-Yun Zhang,Guo-Qing Liao,Yi-Mei Qu,Lu Li,Fang-Fang Liu,Hong-Mei Zhao,Yan-Hui Yin,Wei-Feng Chen,Yu Zhang,Xiao-Song Wang

DOI: https://doi.org/10.1158/0008-5472.22394712

2023-01-01

Abstract:PDF file - 179K, Includes HEPA analysis data, Calculation of DP score, and supplementary references
Supplemental Methods and Legends from Target Identification in Small Cell Lung Cancer Via Integrated Phenotypic Screening and Activity-Based Protein Profiling

Jiannong Li,Bin Fang,Fumi Kinose,Yun Bai,Jae-Young Kim,Yian A. Chen,Uwe Rix,John M. Koomen,Eric B. Haura

DOI: https://doi.org/10.1158/1535-7163.22503178.v1

2023-01-01

Abstract:Supplemental methods and legends for supplemental figures S1 to S3 and supplemental tables S1 to S3
Supplementary Information from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Yunping Qiu,Guoxiang Cai,Bingsen Zhou,Dan Li,Aihua Zhao,Gary Xie,Houkai Li,Sanjun Cai,Dong Xie,Changzhi Huang,Weiting Ge,Zhanxiang Zhou,Lisa X. Xu,Jia Wang,Shusen Zheng,Yun Yen

DOI: https://doi.org/10.1158/1078-0432.22449236.v1

2023-01-01

Abstract:PDF file 119K, This file includes supplementary text and figure legends for supporting figures
Supplementary Data Legends and Methods from Novel Oncogene–Induced Metastatic Prostate Cancer Cell Lines Define Human Prostate Cancer Progression Signatures

Xiaoming Ju,Adam Ertel,Mathew C. Casimiro,Zuoren Yu,Hua Meng,Peter A. McCue,Robin G. Walters,Paolo Fortina,Michael P. Lisanti,Richard G. Pestell

DOI: https://doi.org/10.1158/0008-5472.22396404

2023-01-01

Abstract:PDF file - 132KB, Legends for Supplementary Table 1 and Figures 1-7, and Supplementary Methods

Supplemental Material and Methods from an Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines

An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines

Supplementary Figures and Tables from Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Supplementary Data File 3 from Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Supplementary Data File 5 from Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Supplementary Materials 2 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Supplementary Data File 4 from Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Supplementary Methods and Materials from A Genome-Wide Association Study of Cutaneous Squamous Cell Carcinoma among European Descendants

Supplementary Data from Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Supplementary Figure 1 from Cancer Cell Lines As Genetic Models of Their Parent Histology: Analyses Based on Array Comparative Genomic Hybridization

Supplementary Materials and Methods from Integrative Comparison of mRNA Expression Patterns in Breast Cancers from Caucasian and Asian Americans with Implications for Precision Medicine

Supplementary Figure S10 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Supplementary Text from Integrative Genomic Characterization of Oral Squamous Cell Carcinoma Identifies Frequent Somatic Drivers

Supplementary Data URL from an Integrated View of Copy Number and Allelic Alterations in the Cancer Genome Using Single Nucleotide Polymorphism Arrays

Supplementary Table S4 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Supplementary Methods from Distinguishing Cancer-Associated Missense Mutations from Common Polymorphisms

Supplementary Tables 1, 2, 4, 6, 9 - 12 from Proteogenomic Analysis Reveals Unanticipated Adaptations of Colorectal Tumor Cells to Deficiencies in DNA Mismatch Repair

Supplementary Methods from an Integrated Genome-Wide Approach to Discover Tumor-Specific Antigens As Potential Immunologic and Clinical Targets in Cancer

Supplemental Methods and Legends from Target Identification in Small Cell Lung Cancer Via Integrated Phenotypic Screening and Activity-Based Protein Profiling

Supplementary Information from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Supplementary Data Legends and Methods from Novel Oncogene–Induced Metastatic Prostate Cancer Cell Lines Define Human Prostate Cancer Progression Signatures